SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950103-24-005844
Filing Date
2024-04-26
Accepted
2024-04-26 16:21:49
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM DEFA 14A dp209891_defa14a.htm DEFA14A 44901
2 GRAPHIC image_001.jpg GRAPHIC 4490
3 GRAPHIC image_003.jpg GRAPHIC 1477
4 GRAPHIC image_002.jpg GRAPHIC 1769
5 GRAPHIC image_004.jpg GRAPHIC 7289
6 GRAPHIC image_005.jpg GRAPHIC 1769
7 GRAPHIC image_006.jpg GRAPHIC 1486
8 GRAPHIC image_008.jpg GRAPHIC 887
9 GRAPHIC image_007.jpg GRAPHIC 1486
  Complete submission text file 0000950103-24-005844.txt   75498
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39071 | Film No.: 24884144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)